Form 4/A for ELTX Elicio Therapeutics, Inc.

Accepted 2022-05-27 00:00:00 ET · period of report 2021-02-09 · accession 0001601485-22-000045 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DA	2022-05-27	2021-02-09	ELTX	Venkatesan Jay	See Remarks, Dir	X - OptEx	$6.43	+396.3K	1.60M	+33%	+$2.55M
DA	2022-05-27	2021-02-09	ELTX	Venkatesan Jay	See Remarks, Dir	S - Sale+OE	$16.00	-159.2K	1.37M	-10%	-$2.55M
DA	2022-05-27	2021-02-09	ELTX	Venkatesan Jay	See Remarks, Dir	C - Cnv Deriv	$11.57	+262	1.44M	+0.0%	+$3,031
DA	2022-05-27	2021-02-09	ELTX	Venkatesan Jay	See Remarks, Dir	X - OptEx	$0.00	-396.3K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-02-09	X	A	396,329	$6.43	1,598,440	D	—	—
2	Common	Common Stock	2021-02-09	S	D	159,177	$16.00	1,367,263	D	—	—
3	Common	Common Stock	2021-02-09	C	A	262	$11.57	1,439,525	D	—	—
4	Derivative	Warrant to Purchase Common Stock	2021-02-09	X	D	396,329	$0.00	0	D	$6.43 · — to 2028-07-05	396,329 Common Stock	(F1) On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 396,329 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 159,177 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 237,152 shares of common stock.